Filed 1.1y ago· May 6, 2025
1 day to disclose
Marjorie Taylor Greene
RHouseGeorgia-14
↑bought
FedEx
FDX
$1K-$15K
+22.0% vs S&P 500
Trade dateMay 5, 2025
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.




































































































| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
May 6, 2025 1.1y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | FedEx FDX | May 5, 2025 1 day to disclose | Good buy·+$4.1K+51.4% +22.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Occidental Petroleum OXY Common Stock | May 5, 2025 1 day to disclose | Good buy·+$3.4K+42.0% −1.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Chevron CVX | May 5, 2025 1 day to disclose | Good buy·+$2.9K+36.6% −7.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | DXC Technology DXC Stock | Apr 29, 2025 7 days to disclose | Flat·+0.0% +77.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Boston Scientific BSX Common Stock | Apr 28, 2025 8 days to disclose | Flat·+0.0% +7.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Vaxcyte PCVX Vaxcyte, Inc. - | Apr 28, 2025 8 days to disclose | Good buy·+$4.5K+56.4% +20.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Crinetics Pharmaceuticals CRNX Common Stock | Apr 17, 2025 19 days to disclose | Good buy·+$3K+37.4% −5.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | ChampionX Corporation CHX ChampionX | Apr 17, 2025 19 days to disclose | price pending | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Vaxcyte PCVX Vaxcyte, Inc. - | Apr 15, 2025 21 days to disclose | Good buy·+$5.6K+70.2% +30.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Vaxcyte PCVX Vaxcyte, Inc. - | Apr 14, 2025 22 days to disclose | Good buy·+$4.8K+60.6% +21.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 2, 2025 1.1y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↑bought | Paychex PAYX ⚑ Technology · Science, Space, and Technology | Apr 9, 2025 23 days to disclose | Bad buy·−$2.5K-31.7% −113.3% vs S&P 500 | $1K-$15K midpoint $8K |
May 2, 2025 1.1y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↑bought | IDEXX Laboratories IDXX Stock ⚑ Healthcare · Research and Technology | Apr 9, 2025 23 days to disclose | Good buy·+$3.3K+41.2% +34.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 2, 2025 1.1y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↑bought | IDEXX Laboratories IDXX Stock ⚑ Healthcare · Research and Technology | Apr 7, 2025 25 days to disclose | Good buy·+$3.8K+48.0% +37.5% vs S&P 500 | $1K-$15K midpoint $8K |
May 2, 2025 1.1y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↑bought | IDEXX Laboratories IDXX Stock ⚑ Healthcare · Research and Technology | Apr 4, 2025 28 days to disclose | Good buy·+$3.4K+42.4% +32.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 2, 2025 1.1y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↑bought | IDEXX Laboratories IDXX Stock ⚑ Healthcare · Research and Technology | Apr 1, 2025 31 days to disclose | Good buy·+$2.7K+34.0% +30.4% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Becton Dickinson BDX Common Stock | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Texas Instruments TXN Common Stock | Apr 8, 2025 20 days to disclose | Flat·+0.0% +106.0% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Occidental Petroleum OXY Common Stock | Apr 8, 2025 20 days to disclose | Flat·+0.0% +51.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | FedEx FDX ⚑ Transportation · Transportation and Infrastructure | Apr 8, 2025 20 days to disclose | Flat·+0.0% +49.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | IDEXX Laboratories IDXX Stock | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | CSX Corp CSX CSX ⚑ Transportation · Transportation and Infrastructure | Apr 8, 2025 20 days to disclose | Flat·+0.0% +49.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Dexcom DXCM | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Edison International EIX | Apr 8, 2025 20 days to disclose | Flat·+0.0% +51.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 23, 2025 1.1y ago | ![]() George Whitesides DHouseCalifornia-27 | ↓sold | Netflix NFLX Netflix, Inc. - | Mar 27, 2025 27 days to disclose | Flat·+0.0% +17.1% vs S&P 500 | $100K-$250K midpoint $175K |
Apr 23, 2025 1.1y ago | ![]() George Whitesides DHouseCalifornia-27 | ↓sold | Texas Instruments TXN Common Stock ⚑ Technology · Science, Space, and Technology | Mar 24, 2025 30 days to disclose | Flat·+0.0% +69.6% vs S&P 500 | $50K-$100K midpoint $75K |
Apr 23, 2025 1.1y ago | ![]() George Whitesides DHouseCalifornia-27 | ↓sold | RTX (Raytheon) RTX RTX Corporation ⚑ Defense · Armed Services | Mar 24, 2025 30 days to disclose | Flat·+0.0% +45.1% vs S&P 500 | $50K-$100K midpoint $75K |
Apr 22, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Texas Instruments TXN Common Stock | Mar 31, 2025 22 days to disclose | Good buy·+$5.8K+72.2% −7.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 22, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Texas Instruments TXN Common Stock | Mar 26, 2025 27 days to disclose | Good buy·+$5.4K+67.7% −5.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | HKXCY Unsponsored ADR | Mar 20, 2025 27 days to disclose | Good buy·+$1.1K+13.8% −18.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | ExxonMobil XOM Stock ⚑ Energy · Natural Resources | Mar 3, 2025 44 days to disclose | Good buy·+$3.2K+39.6% +7.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | Starbucks SBUX Stock ⚑ Consumer Cyclical · Highways and Transit | Mar 3, 2025 44 days to disclose | Bad buy·−$1.3K-16.4% −29.1% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | RTX (Raytheon) RTX RTX Corporation | Mar 3, 2025 44 days to disclose | Good buy·+$2.3K+29.0% −20.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | Netflix NFLX Netflix, Inc. - | Mar 3, 2025 44 days to disclose | Bad buy·−$1.2K-14.7% −29.1% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | Chevron CVX ⚑ Energy · Natural Resources | Mar 3, 2025 44 days to disclose | Good buy·+$1.7K+20.9% −10.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | Boston Scientific BSX Common Stock | Mar 3, 2025 44 days to disclose | Bad buy·−$4.3K-54.3% −53.5% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | American Express AXP Stock | Mar 3, 2025 44 days to disclose | Good buy·+$366+4.6% +4.4% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | Freeport-McMoRan FCX Stock ⚑ Basic Materials · Natural Resources | Mar 3, 2025 44 days to disclose | Good buy·+$8K+100.5% +82.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 15, 2025 1.1y ago | ![]() Rick Larsen DHouseWashington-02 | ↑bought | American Express AXP Stock | Apr 9, 2025 6 days to disclose | Good buy·+$1.4K+17.8% +8.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | ![]() Byron Donalds RHouseFlorida-19 | ↓sold | Equifax EFX Equifax, Inc. | Mar 20, 2025 25 days to disclose | Flat·+0.0% +32.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | ![]() Byron Donalds RHouseFlorida-19 | ↓sold | Equifax EFX Equifax, Inc. | Mar 20, 2025 25 days to disclose | Flat·+0.0% +32.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | ![]() Byron Donalds RHouseFlorida-19 | ↓sold | Vertex Pharmaceuticals VRTX - | Mar 20, 2025 25 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | ![]() Byron Donalds RHouseFlorida-19 | ↓sold | Vertex Pharmaceuticals VRTX - | Mar 20, 2025 25 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 11, 2025 1.1y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | FedEx FDX | Apr 8, 2025 3 days to disclose | Good buy·+$5.3K+65.9% +16.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↓sold | IDEX IEX ⚑ Industrials · Aviation | Mar 31, 2025 11 days to disclose | Flat·+0.0% +33.0% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | Lam Research LRCX Stock | Mar 31, 2025 11 days to disclose | Good buy·+$278.4K+371.2% +291.9% vs S&P 500 | $50K-$100K midpoint $75K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | Block XYZ Block, Inc. Class A Common Stock, | Mar 31, 2025 11 days to disclose | Good buy·+$22.7K+30.2% −3.9% vs S&P 500 | $50K-$100K midpoint $75K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | Texas Instruments TXN Common Stock | Mar 31, 2025 11 days to disclose | Good buy·+$23.5K+72.2% −7.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | ![]() Susie Lee DHouseNevada-03 | ↓sold | Starbucks SBUX Stock | Mar 14, 2025 28 days to disclose | Flat·+0.0% +21.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | IDEXX Laboratories IDXX Stock | Mar 13, 2025 29 days to disclose | Good buy·+$11.3K+34.8% +31.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | Vertex Pharmaceuticals VRTX - | Mar 13, 2025 29 days to disclose | Bad buy·−$5.3K-16.2% −19.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | Exponent EXPO | Mar 13, 2025 29 days to disclose | Bad buy·−$6.9K-21.3% −57.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | Texas Instruments TXN Common Stock | Mar 13, 2025 29 days to disclose | Good buy·+$25.4K+78.2% | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | ![]() Carol D. Miller RHouseWest Virginia-01 | ↓sold | Quest Diagnostics DGX Common Stock ⚑ Healthcare · Ways and Means | Mar 10, 2025 32 days to disclose | Flat·+0.0% +0.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↓sold | Lam Research LRCX Stock | Mar 5, 2025 37 days to disclose | Flat·+0.0% +67.1% vs S&P 500 | $50K-$100K midpoint $75K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | Axon Enterprise AXON | Mar 5, 2025 37 days to disclose | Bad buy·−$7.3K-22.6% −51.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↓sold | Becton Dickinson BDX Common Stock | Mar 5, 2025 37 days to disclose | Flat·+0.0% −0.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↓sold | Vaxcyte PCVX Vaxcyte, Inc. - | Mar 5, 2025 37 days to disclose | Flat·+0.0% +28.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↓sold | American Express AXP Stock | Mar 5, 2025 37 days to disclose | Flat·+0.0% +3.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 10, 2025 1.2y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Crinetics Pharmaceuticals CRNX Common Stock | Mar 19, 2025 22 days to disclose | Flat·+0.0% +32.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 9, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Texas Instruments TXN Common Stock | Mar 10, 2025 30 days to disclose | Good buy·+$5.3K+65.9% −11.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 8, 2025 1.2y ago | ![]() Greg Landsman DHouseOhio-01 | ↓sold | L3Harris Technologies LHX Stock | Mar 27, 2025 12 days to disclose | Flat·+0.0% +46.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 8, 2025 1.2y ago | ![]() Greg Landsman DHouseOhio-01 | ↓sold | Equinix EQIX Equinix, Inc. - | Mar 27, 2025 12 days to disclose | Flat·+0.0% +7.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 8, 2025 1.2y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | TJX Companies TJX | Mar 10, 2025 29 days to disclose | Good buy·+$2.5K+30.7% +10.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 8, 2025 1.2y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | TJX Companies TJX | Mar 10, 2025 29 days to disclose | Good buy·+$2.5K+30.7% +10.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2025 1.2y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | FedEx FDX | Apr 4, 2025 3 days to disclose | Good buy·+$4.5K+56.4% +8.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2025 1.2y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Lam Research LRCX Stock | Apr 4, 2025 3 days to disclose | Good buy·+$38.4K+479.7% +376.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2025 1.2y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | FedEx FDX | Apr 3, 2025 4 days to disclose | Good buy·+$4.2K+52.2% +13.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2025 1.2y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Hologic HOLX | Mar 31, 2025 7 days to disclose | price pending | $1K-$15K midpoint $8K |
Apr 7, 2025 1.2y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Boston Scientific BSX Common Stock | Mar 17, 2025 21 days to disclose | Flat·+0.0% +1.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 2, 2025 1.2y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↑bought | IDEXX Laboratories IDXX Stock ⚑ Healthcare · Research and Technology | Mar 14, 2025 19 days to disclose | Good buy·+$2.8K+35.0% +32.5% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Extra Space Storage EXR Stock ⚑ Real Estate · Economic Development, Public Buildings, and Emergency Management | Feb 25, 2025 30 days to disclose | Flat·+0.0% +4.3% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | CSX Corp CSX CSX ⚑ Transportation · Transportation and Infrastructure | Feb 25, 2025 30 days to disclose | Good buy·+$3.3K+41.7% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Textron TXT | Feb 25, 2025 30 days to disclose | Flat·+0.0% +26.3% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Freeport-McMoRan FCX Stock ⚑ Basic Materials · Conservation, Research, and Biotechnology | Feb 25, 2025 30 days to disclose | Flat·+0.0% +15.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | ExxonMobil XOM Stock | Feb 25, 2025 30 days to disclose | Flat·+0.0% +29.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Teleflex TFX | Feb 25, 2025 30 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Occidental Petroleum OXY Common Stock | Feb 25, 2025 30 days to disclose | Good buy·+$4.1K+12.7% −16.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Dexcom DXCM | Feb 25, 2025 30 days to disclose | Bad buy·−$1.4K-17.6% −17.4% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | IDEXX Laboratories IDXX Stock | Feb 25, 2025 30 days to disclose | Good buy·+$1.5K+19.1% +19.3% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 20, 2025 1.2y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↓sold | T TPX Common Stock | Feb 28, 2025 20 days to disclose | price pending | $1K-$15K midpoint $8K |
Mar 20, 2025 1.2y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↑bought | Paychex PAYX ⚑ Technology · Science, Space, and Technology | Feb 27, 2025 21 days to disclose | Bad buy·−$2.6K-32.9% −99.3% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 20, 2025 1.2y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↓sold | T TPX Common Stock | Feb 22, 2025 26 days to disclose | price pending | $1K-$15K midpoint $8K |
Mar 20, 2025 1.2y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↓sold | T TPX Common Stock | Feb 21, 2025 27 days to disclose | price pending | $1K-$15K midpoint $8K |
Mar 20, 2025 1.2y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↑bought | Paychex PAYX ⚑ Technology · Science, Space, and Technology | Feb 21, 2025 27 days to disclose | Bad buy·−$2.6K-32.8% −90.4% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 20, 2025 1.2y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↓sold | T TPX Common Stock | Feb 17, 2025 31 days to disclose | price pending | $1K-$15K midpoint $8K |
Mar 20, 2025 1.2y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↓sold | T TPX Common Stock | Feb 16, 2025 32 days to disclose | price pending | $1K-$15K midpoint $8K |
Mar 20, 2025 1.2y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↓sold | T TPX Common Stock | Feb 15, 2025 33 days to disclose | price pending | $1K-$15K midpoint $8K |
Mar 20, 2025 1.2y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↑bought | Paychex PAYX ⚑ Technology · Science, Space, and Technology | Feb 9, 2025 39 days to disclose | Bad buy·−$2.6K-32.1% −88.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 20, 2025 1.2y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↑bought | Paychex PAYX ⚑ Technology · Science, Space, and Technology | Feb 5, 2025 43 days to disclose | Bad buy·−$2.7K-33.8% −91.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 19, 2025 1.2y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Blackstone BX | Mar 17, 2025 2 days to disclose | Bad buy·−$2.1K-26.0% −31.6% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 12, 2025 1.2y ago | ![]() Julie Johnson DHouseTexas-32 | ↑bought | RTX (Raytheon) RTX JT RTX Corporation ⚑ Defense · Foreign Affairs | Feb 14, 2025 26 days to disclose | Good buy·+$3.3K+41.1% −8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 12, 2025 1.2y ago | ![]() Julie Johnson DHouseTexas-32 | ↓sold | MarketAxess Holdings MKTX Common Stock | Feb 12, 2025 28 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 12, 2025 1.2y ago | ![]() Julie Johnson DHouseTexas-32 | ↑bought | Freeport-McMoRan FCX Stock | Feb 12, 2025 28 days to disclose | Good buy·+$7K+87.7% +71.7% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 12, 2025 1.2y ago | ![]() Julie Johnson DHouseTexas-32 | ↑bought | Edison International EIX | Feb 12, 2025 28 days to disclose | Good buy·+$2.4K+30.6% +6.2% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 12, 2025 1.2y ago | ![]() Julie Johnson DHouseTexas-32 | ↓sold | Amdocs Ltd. DOX Amdocs Limited - Ordinary Shares | Feb 11, 2025 29 days to disclose | Flat·+0.0% +25.7% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 12, 2025 1.2y ago | ![]() Julie Johnson DHouseTexas-32 | ↑bought | NXP Semiconductors NXPI Stock ⚑ Technology · Emergency Management and Technology | Feb 5, 2025 35 days to disclose | Good buy·+$3.4K+42.4% −15.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 9, 2025 1.2y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | Exponent EXPO | Feb 24, 2025 13 days to disclose | Bad buy·−$7.8K-24.0% −49.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 9, 2025 1.2y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | RTX (Raytheon) RTX RTX Corporation ⚑ Defense · Aviation | Feb 24, 2025 13 days to disclose | Good buy·+$13K+39.9% −13.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 9, 2025 1.2y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↓sold | Block XYZ Block, Inc. Class A Common Stock, | Feb 24, 2025 13 days to disclose | Flat·+0.0% +25.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 9, 2025 1.2y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | Occidental Petroleum OXY Common Stock ⚑ Energy · Railroads, Pipelines, and Hazardous Materials | Feb 24, 2025 13 days to disclose | Good buy·+$3.4K+10.5% −16.7% vs S&P 500 | $15K-$50K midpoint $32.5K |